Boquiren Virginia M, Esplen Mary Jane, Wong Jiahui, Toner Brenda, Warner Ellen, Malik Noorulain
Behavioural Sciences and Health Research Division, University Health Network, Toronto, ON, Canada.
College of Nursing, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Psychooncology. 2016 Jan;25(1):66-76. doi: 10.1002/pon.3819. Epub 2015 Apr 27.
Breast cancer treatments and the traumatic nature of the cancer experience frequently elicit considerable sexual difficulties. Breast cancer survivors (BCS) experiencing body image (BI) issues may represent a vulnerable group for developing sexual dysfunction posttreatment. The current study explores sexual functioning (SF) in this unique clinical group.
A descriptive study assessed 127 BCS who were engaged in sexual activity. Standardized baseline measures included the following: BI Scale, BI after Breast Cancer Questionnaire, Female Sexual Function Index (FSFI), Kansas Marital Satisfaction Scale, and Functional Assessment of Cancer Therapy - Breast. Levels of SF were compared with BCS, heterogeneous cancer, and healthy female populations. Correlational analyses were conducted between SF, BI, relationship, and health-related quality of life variables. Guided by a conceptual framework, regression analyses were conducted to determine significant demographic, clinical, and psychosocial predictors of sexual desire, satisfaction, and overall SF.
Eighty-three per cent of BCS met the FSFI clinical cutoff score for a sexual dysfunction. Participants exhibited poorer SF when compared with other female cancer and healthy groups. No significant correlations were found between BI questionnaire total scores and SF. BI after Breast Cancer Questionnaire - Body Stigma subscale showed significant associations with FSFI Arousal, Orgasm, Satisfaction (average r = -0.23), and overall SF (r = -0.25). Vaginal dryness (β = -0.50), body stigma (β = -0.24), and relationship satisfaction (β = 0.27) were significant predictors of overall SF.
Difficulties in SF appear to be highly prevalent in BCS experiencing BI disturbance posttreatment. Brief screening tools assessing SF should adopt a biopsychosocial model, which includes questions regarding vaginal dryness, relationship satisfaction, and body stigma issues.
乳腺癌治疗以及癌症经历带来的创伤性常常引发诸多性方面的困难。经历身体形象(BI)问题的乳腺癌幸存者(BCS)可能是治疗后发生性功能障碍的脆弱群体。本研究探讨了这一独特临床群体的性功能(SF)。
一项描述性研究评估了127名有性行为的BCS。标准化基线测量包括:身体形象量表、乳腺癌后身体形象问卷、女性性功能指数(FSFI)、堪萨斯婚姻满意度量表以及癌症治疗功能评估 - 乳腺。将性功能水平与BCS群体、异质性癌症群体和健康女性群体进行比较。对性功能、身体形象、人际关系和健康相关生活质量变量进行了相关性分析。在一个概念框架的指导下,进行回归分析以确定性欲、满意度和总体性功能的显著人口统计学、临床和社会心理预测因素。
83%的BCS达到了FSFI性功能障碍的临床临界分数。与其他女性癌症患者和健康组相比,参与者的性功能较差。身体形象问卷总分与性功能之间未发现显著相关性。乳腺癌后身体形象问卷 - 身体耻辱子量表与FSFI的性唤起、性高潮、满意度(平均r = -0.23)以及总体性功能(r = -0.25)显示出显著关联。阴道干燥(β = -0.50)、身体耻辱感(β = -0.24)和关系满意度(β = 0.27)是总体性功能的显著预测因素。
在治疗后经历身体形象障碍的BCS中,性功能障碍似乎非常普遍。评估性功能的简短筛查工具应采用生物心理社会模型,其中包括关于阴道干燥、关系满意度和身体耻辱问题的提问。